Barzilai Medical Center   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Ashkelon Israel (1961)

Organization Overview

First Clinical Trial
2008
NCT00626652
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Barzilai Medical Center | Barzilai Medical Center, Department of Neurology, Movement disorders unit, Ashkelon, Israel | Barzili Medical Center

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Fibrillation (Phase 2)

Blepharitis (Phase 4)

Bronchopulmonary Dysplasia (Phase 2)

Fractures, Bone (Phase 2)

Hyperplasia (Phase 2)

Inflammation (Phase 4)

Parkinson Disease (Phase 2)

Radius Fractures (Phase 2)

Respiratory Distress Syndrome (Phase 3)

Respiratory Distress Syndrome, Newborn (Phase 3)

Sepsis (Phase 3)

Virus Diseases (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 12
  • # of Trial APIs: 16